Search Results - "Lawrence G. Iben"
-
1
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780
Published in International journal of alzheimer's disease (2014)“…Alzheimer’s disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid…”
Get full text
Journal Article -
2
Synergistic inhibition of Aβ production by combinations of γ-secretase modulators
Published in European journal of pharmacology (05-10-2017)“…Alzheimer's disease is associated with the accumulation of amyloid-β (Aβ) in the brain. In particular, the 42-amino acid form, Aβ1-42, is thought to play a key…”
Get full text
Journal Article -
3
Acyl Guanidine Inhibitors of β‑Secretase (BACE-1): Optimization of a Micromolar Hit to a Nanomolar Lead via Iterative Solid- and Solution-Phase Library Synthesis
Published in Journal of medicinal chemistry (08-11-2012)“…This report describes the discovery and optimization of a BACE-1 inhibitor series containing an unusual acyl guanidine chemotype that was originally…”
Get full text
Journal Article -
4
The Amyloid-β Rise and γ-Secretase Inhibitor Potency Depend on the Level of Substrate Expression
Published in The Journal of biological chemistry (22-08-2008)“…The amyloid-β (Aβ) peptide, which likely plays a key role in Alzheimer disease, is derived from the amyloid-β precursor protein (APP) through consecutive…”
Get full text
Journal Article -
5
Heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 receptor antagonist
Published in Bioorganic & medicinal chemistry letters (01-07-2013)“…A convergent synthesis route for the heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 antagonist 2 was developed and the structure activity…”
Get full text
Journal Article -
6
Cloning, pharmacological characterization and distribution of a novel galanin receptor
Published in Brain research. Molecular brain research. (01-11-1997)“…The neuropeptide galanin mediates a diverse spectrum of biological activities by interacting with specific G-protein-coupled receptors. Through expression…”
Get full text
Journal Article -
7
-
8
Signal Peptide Peptidase and γ-Secretase Share Equivalent Inhibitor Binding Pharmacology
Published in The Journal of biological chemistry (21-12-2007)“…The enzyme γ-secretase has long been considered a potential pharmaceutical target for Alzheimer disease. Presenilin (the catalytic subunit of γ-secretase) and…”
Get full text
Journal Article -
9
[ 3H]BMS-599240 — A novel tritiated ligand for the characterization of BACE1 inhibitors
Published in European journal of pharmacology (28-09-2008)“…In this report we describe a novel radioligand, [ 3H](S)-2-((S)-3-Acetylamino-3- sec-butyl-2-oxo-pyrrolidin-1-yl)-…”
Get full text
Journal Article -
10
Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor
Published in Brain research. Molecular brain research. (15-07-1998)“…The neuropeptide galanin mediates a diverse spectrum of biological activities by interacting with specific G protein-coupled receptors. We have used homology…”
Get full text
Journal Article -
11
Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists
Published in ACS medicinal chemistry letters (08-03-2012)“…A novel class of bicyclo[3.1.0]hexanylpiperazine neuropeptide Y (NPY) Y1 antagonists has been designed and synthesized. Scatchard binding analysis showed…”
Get full text
Journal Article -
12
Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists
Published in Bioorganic & medicinal chemistry (15-08-2006)“…A series of novel 5,5-diphenylimidazolones was synthesized and evaluated for activity against the human neuropeptide Y5 receptor. The 3-pyridyl analog 46…”
Get full text
Journal Article -
13
4-Substituted anilides as selective melatonin MT2 receptor agonists
Published in Bioorganic & medicinal chemistry letters (23-02-2004)“…A series of 4-substituted anilides with human melatonergic affinity is reported. Butyramides 26, 39, 42, 52, 57, and 58 all demonstrated subnanomolar MT(2)…”
Get full text
Journal Article -
14
Differentially functionalized diamines as novel ligands for the NPY2 receptor
Published in Bioorganic & medicinal chemistry letters (01-09-2003)“…The synthesis of novel ligands for the NPY(2) receptor using solid phase split pool methodology is described. One of the analogues, diamine 16, was found to be…”
Get full text
Journal Article -
15
Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtype
Published in Neurochemical research (1995)“…The melanocortin (MC) peptides mediate a diverse spectrum of biological activities in both the central nervous system and peripheral tissues by interacting…”
Get full text
Journal Article -
16
A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors
Published in Journal of neurochemistry (01-01-1993)“…Molecular cloning of the rat and human 5-hydroxytryptamine1B (5-HT1B) receptors has revealed that the primary amino acid sequence of these two receptors is >…”
Get more information
Journal Article -
17
Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells
Published in Brain research. Molecular brain research. (28-12-1995)“…Galanin is a ubiquitous neuropeptide that regulates a wide array of physiological processes via interaction with specific G protein-coupled receptors. A rat…”
Get full text
Journal Article -
18
Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y 1 receptor antagonist
Published in European journal of pharmacology (20-08-2008)“…Treatment of obesity is still a large unmet medical need. Neuropeptide Y is the most potent orexigenic peptide in the animal kingdom. Its five cloned G-protein…”
Get full text
Journal Article -
19
Identification and Preclinical Pharmacology of the [gamma] -Secretase Modulator BMS-869780
Published in International journal of alzheimer's disease (01-01-2014)“…Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid…”
Get full text
Journal Article -
20
Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist
Published in European journal of pharmacology (20-08-2008)“…Treatment of obesity is still a large unmet medical need. Neuropeptide Y is the most potent orexigenic peptide in the animal kingdom. Its five cloned G-protein…”
Get full text
Journal Article